NEVVI Medicare utilization intelligence

← back

DIVERS, STEPHENM.D. NPI 1760469407 Clinician

Medical Oncology · HOT SPRINGS, AR

Specialty Medical Oncology — from billed Medicare claims
Trained LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS — medical school, self-reported to CMS
In practice about 28 years since medical school (class of 1998, self-reported to CMS)
Location HOT SPRINGS, AR · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 76 codes billed · 332,370 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
AMERICAN ONCOLOGY PARTNERS PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-12

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9299 Injection, nivolumab, 1 mg
J9271 Injection, pembrolizumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0185 Injection, aprepitant, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J1437 Injection, ferric derisomaltose, 10 mg
J9267 Injection, paclitaxel, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
36415 Insertion of needle into vein for collection of blood sample
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
J9395 Injection, fulvestrant, 25 mg
J0461 Injection, atropine sulfate, 0.01 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J2405 Injection, ondansetron hydrochloride, per 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J0640 Injection, leucovorin calcium, per 50 mg
96375 Injection of additional new drug or substance into vein
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J9045 Injection, carboplatin, 50 mg
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J9190 Injection, fluorouracil, 500 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J3489 Injection, zoledronic acid, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
71260 Ct scan of chest with contrast
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
74177 Ct scan of abdomen and pelvis with contrast
96415 Administration of chemotherapy into vein, each additional hour
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
71250 Ct scan of chest without contrast
81002 Urinalysis, manual test
J3490 Unclassified drugs
85045 Red blood count, automated test
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
J0696 Injection, ceftriaxone sodium, per 250 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J7030 Infusion, normal saline solution , 1000 cc
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96523 Irrigation of implanted venous access drug delivery device
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96361 Infusion into a vein for hydration, each additional hour
74176 Ct scan of abdomen and pelvis without contrast
38222 Biopsy and aspiration of bone marrow sample for diagnosis
78816 Nuclear medicine study whole body with ct scan
96409 Administration of chemotherapy into vein using push technique
96374 Injection of drug or substance into vein
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
70491 Ct scan of soft tissue of neck with contrast
96360 Infusion into a vein for hydration, 31-60 minutes
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.